new glp-1 drug retatrutide Treatment with retatrutide, an agonist to GLP-1, GIP, and glucagon New weight loss drug dubbed

Key therapies such as antacids, proton pump inhibitors (PPIs), H2 receptor antagonists, and prokinetics continue to dominate, with both OTC and prescription drugs making management more accessible

Although GLP-1 RAs have been shown to promote greater weight loss than lifestyle intervention in patients without psychiatric disease, the efficacy, safety, and overall applicability of this strategy for patients with psychiatric disease was uncertain

If Ozempic-related dental problems do develop, here is a rough guide to what treatment might cost in Australia: Fluoride varnish application : $30 to $60 per visit Dental filling : $150 to $350+ depending on size and material Dental crown : $1,200 to $2,000+ Root canal treatment : $800 to $1,500+ Private health insurance (extras cover) may cover a portion of these costs, though most policies have annual limits of around $1,000 to $1,500 for major dental work

First developed for diabetes, GLP-1 agonists have since proven highly effective for obesity and metabolic disease, opening the door to much broader applications